158 filings
Page 5 of 8
424B5
3e8ilqqhu86k9 rgfv
23 Sep 20
Prospectus supplement for primary offering
4:19pm
CORRESP
fvdxryi0f5z5u2 bfw
21 Sep 20
Correspondence with SEC
12:00am
UPLOAD
o08sshqsh7srxjhy
18 Sep 20
Letter from SEC
12:00am
8-K
lujcjp84pev3ea q0
5 Aug 20
Kezar Life Sciences Reports Second Quarter 2020 Financial Results and Provides Clinical and Business Update
4:05pm
8-K
9n48ge
26 Jun 20
Submission of Matters to a Vote of Security Holders
4:40pm
8-K
gs303bu6pgr
10 Jun 20
Kezar Announces Pricing of a Public Offering of $46.7 million of Common Stock andPre-Funded Warrants
9:29am
424B5
t6ra7
10 Jun 20
Prospectus supplement for primary offering
9:27am
424B5
zdmacv jfa1
8 Jun 20
Prospectus supplement for primary offering
4:07pm
8-K
jd716sw6pg
8 Jun 20
Special Note Regarding Forward-looking Statements
6:21am
424B5
0nddvfinx jp
8 Jun 20
Prospectus supplement for primary offering
6:17am
8-K
8df66
3 Jun 20
Kezar Provides Data Update from MISSION Study of KZR-616
5:17pm
8-K
41tjj6 914
7 May 20
Kezar Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
4:08pm
DEFA14A
9j2 2ssz08wvtz0a4w5
29 Apr 20
Additional proxy soliciting materials
4:58pm
8-K
ak5dvr3u7 tnmy40
9 Apr 20
Kezar Provides Statement Regarding COVID-19 Pandemic
8:31am
S-8
vfw9 577c6eb
12 Mar 20
Registration of securities for employees
5:07pm